CrossrefInfokarte
Osteoporosis or fracture risk associated with thiazolidinedione and proton pump inhibitor co‐administration in patients with type 2 diabetes mellitus
Journal of Clinical Pharmacy and Therapeutics · 2022-07 · 47 (7) · 1028-1035
DOI: 10.1111/jcpt.13640 ↗Abstract
Kein Abstract verfügbar.
EUVIMED